These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14179485)

  • 1. AN ASSAY FOR ANTIHAEMOPHILIC FACTOR (FACTOR VIII) WITH SOME CONSIDERATIONS AFFECTING THE ESTABLISHMENT OF A STANDARD REFERENCE PREPARATION.
    KEKWICK RA; WALTON PL
    Br J Haematol; 1964 Jul; 10():299-313. PubMed ID: 14179485
    [No Abstract]   [Full Text] [Related]  

  • 2. "THROMBOCYTOPENIC SERUM": AN ARTIFICIAL FACTOR VIII-DEFICIENT REAGENT.
    DAVIDSON E; TOMLIN S
    J Clin Pathol; 1964 Mar; 17(2):188-90. PubMed ID: 14149948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN.
    NEMERSON Y; SPAET TH
    Blood; 1964 May; 23():657-68. PubMed ID: 14142504
    [No Abstract]   [Full Text] [Related]  

  • 4. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of a non-hemophilic reagent for factor VIII (AHF) determination.
    Ruiz de Angulo M; Frommel D
    Am J Clin Pathol; 1974 Feb; 61(2):160-5. PubMed ID: 4855806
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of activated partial thromboplastin reagents.
    Sibley C; Singer JW; Wood RJ
    Am J Clin Pathol; 1973 Apr; 59(4):581-6. PubMed ID: 4692988
    [No Abstract]   [Full Text] [Related]  

  • 8. THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).
    ABILDGAARD CF; CORNET JA; FORT E; SCHULMAN I
    Br J Haematol; 1964 Apr; 10():225-37. PubMed ID: 14141621
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biological standard for measurement of blood coagulation Factor VIII activity.
    Bangham DR; Biggs R; Brozović M; Denson KW; Skegg JL
    Bull World Health Organ; 1971; 45(3):337-51. PubMed ID: 5316913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the purification and stability of human antihaemophilic factor (factor 8).
    Kekwick RA; Walton PL
    Br J Haematol; 1965 Sep; 11(5):537-48. PubMed ID: 5838896
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of procoagulant antihaemophilic factor in vitro.
    Mohanty D; Hilgard P
    Lancet; 1979 Jan; 1(8107):101. PubMed ID: 84101
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII deficient plasma for laboratory tests prepared from normal plasma and a human antibody.
    Exner T; Rickard KA; Speers S
    Haemostasis; 1977; 6(3):157-62. PubMed ID: 885378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the determination of AHF activity feasible for individual cryoprecipitates?
    Frommel D; de Angulo MR
    Vox Sang; 1975; 29(3):228-30. PubMed ID: 1136334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of ampholines on blood coagulation: 1. Activation of factor VIII (antihemophilic globulin A)].
    Liebe S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(4):454-61. PubMed ID: 54294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of assay of factor VIII by automated partial thromboplastin time.
    Burka ER; Holburn RR; Puffer T; Behrendt T
    Am J Clin Pathol; 1973 May; 59(5):751-4. PubMed ID: 4702693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.